AtriCure (ATRC) Operating Expenses (2010 - 2026)

AtriCure (ATRC) has 17 years of Operating Expenses data on file, last reported at $108.8 million in Q1 2026.

• On a quarterly basis, Operating Expenses rose 10.35% year-over-year to $108.8 million in Q1 2026; TTM through Mar 2026 was $420.4 million, a 6.73% increase from a year earlier, with the FY2025 full-year figure at $410.2 million, up 5.85% from the prior year.
• Operating Expenses for Q1 2026 stood at $108.8 million, up from $102.8 million in the prior quarter.
• Over the last five years, Operating Expenses for ATRC reached as high as $108.8 million in Q1 2026 and fell as low as $69.2 million in Q4 2022.
• Historically, Operating Expenses has averaged $89.5 million across 5 years, with a median of $92.2 million in 2024.
• Across the five-year window, Operating Expenses surged 255.97% in 2022 and decreased 4.01% in 2025, its largest moves.
• Year by year, Operating Expenses stood at $69.2 million in 2022, then advanced by 27.78% to $88.5 million in 2023, then advanced by 21.09% to $107.1 million in 2024, then retreated by 4.01% to $102.8 million in 2025, then advanced by 5.77% to $108.8 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $108.8 million in Q1 2026, $102.8 million in Q4 2025, and $101.1 million in Q3 2025.